Crystal Critters: Improving Sustainability in Spray Cooling Heat Exchange

Researchers use optical and scanning electron microscopy to describe the phenomenon of self-ejecting crystals from heated, nanotextured superhydrophobic materials Water is a vital part of our every day lives. In developed countries, water also plays a critical role in cooling thermoelectric power plants. Evaporation is part of the cooling process and can result in mineral... Read more

Xylem to Host 2021 Investor Day on September 30

RYE BROOK, N.Y.–(BUSINESS WIRE)–Aug. 12, 2021– Xylem, Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today announced it will host its 2021 Investor Day on September 30 beginning at 8:30 am, U.S. Eastern time. Patrick Decker, Xylem’s president and CEO, Sandy Rowland, Senior Vice President... Read more

Xylem Inc. Declares Third Quarter Dividend Of 28 Cents Per Share

RYE BROOK, N.Y.–(BUSINESS WIRE)–Aug. 11, 2021– The Board of Directors of Xylem Inc. (NYSE: XYL) has declared a third quarter dividend of $0.28 per share payable on September 23, 2021 to shareholders of record as of August 26, 2021. About Xylem Xylem (XYL) is a leading global water technology company committed to solving critical water... Read more

New BD Benchtop Cell Analyzer Enhances Laboratory Access and Accelerates Scientific Research

FRANKLIN LAKES, N.J., Aug. 11, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of a new benchtop cell analyzer that brings sophisticated flow cytometry capabilities to laboratories of all sizes. The new BD FACSymphony™ A1 Cell Analyzer is a fluorescence-activated cell analyzer that offers advanced... Read more

GE Healthcare Announces Strategic Collaboration Agreement with AWS to Transform Care Delivery and Help Clinicians Improve Patient Care

 GE Healthcare Announces Strategic Collaboration Agreement with AWS to Transform Care Delivery and Help Clinicians Improve Patient Care  ·       GE Healthcare to make imaging applications, healthcare workflows, and data and analytics more accessible to benefit medical professionals, AI developers, and patients ·       Helps the healthcare industry transition to a virtualized and distributed care model by... Read more

Thermo Fisher Scientific Announces Offering of USD-Denominated Senior Notes

WALTHAM, Mass., Aug. 9, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it intends to offer USD-denominated senior notes. Thermo Fisher intends to use the net proceeds of the Offering to pay a portion of the cash consideration payable for the pending acquisition of PPD, Inc., a Delaware corporation. The joint... Read more

GE Healthcare Brings Radiology Without Walls to Resource-Constrained Small Imaging Centers With AI-Enabled, Cloud Imaging Solution

GE Healthcare Brings Radiology Without Walls to Resource-Constrained Small Imaging Centers With AI-Enabled, Cloud Imaging Solution ·       Edison True PACS[1] is a transformative system, offering AI-enabled decision support to help radiologists adapt to higher workloads and increased exam complexity, and improve diagnostic accuracy ·       Innovative, cloud-based system removes barriers to adopting new diagnostic radiology efficiency... Read more

Thermo Fisher Scientific Updates Customizable TaqMan SARS-CoV-2 Mutation Panel to Detect Delta and Lambda Variants

Thermo Fisher Scientific Updates Customizable TaqMan SARS-CoV-2 Mutation Panel to Detect Delta and Lambda Variants CARLSBAD, Calif., Aug. 9, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced it has updated its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to detect the Delta and Lambda strains. First launched in March 2021,... Read more

[Ad hoc announcement pursuant to Art. 53 LR] Phase III study shows Roche's Polivy plus R-CHP is the first regimen in 20 years to significantly improve outcomes in previously untreated aggressive form of lymphoma compared to standard of care

Pivotal phase III POLARIX trial comparing Polivy in combination with chemotherapy regimen R-CHP versus the standard of care R-CHOP in treatment of first-line diffuse large B-cell lymphoma (DLBCL) met its primary endpoint of investigator-assessed progression-free survival Prolonging survival without disease advancement could be transformative for newly diagnosed DLBCL patients as currently 40% of patients relapse... Read more